Consistently, pirfenidone was reported to attenuate myocardial infarction-induced cardiac fibrosis in a rat model by activating LXR-α and controlling the feedback loop of the AT1R/p38-MAPK/RAS axis [32]. Here, NR1H3 is linked to myocardial infarction.